April 15, 2023Angiology
Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review
Why the study?
Optimal dosing for pharmaceutical reperfusion therapy in acute PE is not established, higher doses increase major bleeding risk, and dose-finding studies are lacking.
Does reduced-dose thrombolysis improve efficacy and reduce major bleeding in patients with acute pulmonary embolism?
Population
Patients with acute PE
Comparison
Low-dose thrombolysis administered through a peripheral vein
Design
Systematic review
Authors
Discussion
Loading...
Member takes
Implication
Supports reduced-dose thrombolysis in acute PE to balance efficacy and bleeding; extends systematic review evidence on optimized regimens.
Structured PICO
Does reduced-dose thrombolysis improve efficacy and reduce major bleeding in patients with acute pulmonary embolism?
P
Population
Patients with acute pulmonary embolism
I
Intervention
Reduced-dose (low-dose) systemic thrombolysis administered through a peripheral vein
Emerging evidence suggests reduced-dose systemic thrombolysis may be efficacious for acute pulmonary embolism while lowering the risk of major bleeding.
Cite This Study
Murguía et al. (2023) studied this question.